CAS 958772-66-2

Formule : C27H33N5O5S

InChI : InChI=1S/C27H33N5O5S/c1-5-17-10-6-8-12-20(17)29-23(33)16-38-26(36)32-31-24(34)22(30-25(35)37-27(2,3)4)14-18-15-28-21-13-9-7-11-19(18)21/h6-13,15,22,28H,5,14,16H2,1-4H3,(H,29,33)(H,30,35)(H,31,34)(H,32,36)/t22-/m0/s1

Code InChI : OTIWAYTTYNFEKL-QFIPXVFZSA-N

SMILES : CCC1=CC=CC=C1NC(=O)CSC(=O)NNC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)OC(C)(C)C

SID 26681509

CAS : 958772-66-2

SID 26681509

Formule : C₂₇H₃₃N₅O₅S

Degré de pureté : 99%

Masse moléculaire : 539.65

Ref: 54-BUP04610

SID 26681509

CAS : 958772-66-2

Formule : C₂₇H₃₃N₅O₅S

Degré de pureté : 98%

Masse moléculaire : 539.6464

Ref: IN-DA01ENP1

SID 26681509

CAS : 958772-66-2

S-(2-((2-Ethylphenyl)amino)-2-oxoethyl) 2-((tert-butoxycarbonyl)-L-tryptophyl)hydrazine-1-carbothioate

Formule : C₂₇H₃₃N₅O₅S

Degré de pureté : 98%

Masse moléculaire : 539.65

Ref: IN-DG00795866

SID 26681509

CAS : 958772-66-2

SID 26681509 is an enzyme inhibitor that inhibits toll-like receptor (TLR) signaling pathways. TLRs are a family of proteins that act as pattern recognition receptors for the detection of microbial or viral components. SID 26681509 has been shown to inhibit HIV infection in primary cells and to induce autophagy, which may be due to its ability to inhibit methyl transferase activity. It also has been shown to reduce inflammation in mouse models of autoimmune diseases by inhibiting chemoattractant protein expression.

Formule : C₂₇H₃₃N₅O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 539.65 g/mol

Ref: 3D-INB77266

SID 26681509

CAS : 958772-66-2

SID 26681509 is a selective, reversible and competitive human cathepsin L inhibitor (IC50 of 56 nM).

Formule : C₂₇H₃₃N₅O₅S

Degré de pureté : 99.18%

Couleur et forme : White Solid

Masse moléculaire : 539.65

Ref: TM-T12909